CXCR3 predicts the prognosis of endometrial adenocarcinoma

CXCR3 predicts the prognosis of endometrial adenocarcinoma

Abstract Objectives Currently, endometrial adenocarcinoma lacks an effective prognostic indicator. This study was to develop and validate a gene biomarker and a nomogram to predict the survival of endometrial adenocarcinoma, explore potential mechanisms and select sensitive drugs. Methods 425 endome...

Full description

Bibliographic Details
Main Authors: He Dong, Mengzi Sun, Hua Li, Ying Yue
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Medical Genomics
Subjects:
Endometrial adenocarcinoma
Immune
Gene marker
Prognosis
Nomogram
Online Access:https://doi.org/10.1186/s12920-023-01451-9

Internet

https://doi.org/10.1186/s12920-023-01451-9

Similar Items